2DA0 Dasqupta, Indranil - Thomas Jefferson University
Thomas Jefferson University
Sidney Kimmel Medical College
Department of Medicine

Dasqupta, Indranil

< Back

Profile

ixd197

Indranil Dasgupta, MD, FACC, FACP, FAHA

Contact Dr. Dasgupta

925 Chestnut Street
Mezzanine Level
Philadelphia, PA 19107

(215) 955-4260
(215) 503-3976 fax

Medical School

St. George's Unive 4344 rsity Medical School, Grenada - 1994

Residency

Medical College of Pennsylvania (MCP)
Hahnemann University Hospital

Fellowship

Hahnemann University Hospital
Robert Wood Johnson University Hospital

Board Certification

Internal Medicine
Cardiovascular Disease
Diplomate of the ACPE

Hospital Appointment

Thomas Jefferson University Hospital

Publications

Most Recent Peer-Reviewed Publications

  1. Renal Denervation in Patients With Uncontrolled Hypertension and Confirmed Adherence to Antihypertensive Medications
  2. Renal artery sympathetic denervation: observations from the UK experience
  3. Serum tryptase concentration and progression to end-stage renal disease
  4. Cognitive impairment in hemodialysis patients: What can slow this decline?
  5. Non-adherence to antihypertensive medication is very common among resistant hypertensives: Results of a directly observed therapy clinic
  6. Poor adherence to antihypertensive drugs
  7. A Novel 'dilute-and-shoot' liquid chromatography-tandem mass spectrometry method for the screening of antihypertensive drugs in urine
  8. Renal sympathetic denervation for resistant hypertension: A transiently sustained placebo effect¿
  9. Do Obese Individuals With Hypertension Have More Difficult-to-Control Blood Pressure and End Organ Damage Than Their Nonobese Counterparts?
  10. Measurement of arterial stiffness in subjects with and without renal disease: Are changes in the vessel wall earlier and more sensitive markers of cardiovascular disease than intima media thickness and pulse pressure?
  11. Is there a difference in progression of renal disease between South Asian and white European diabetic adults with moderately reduced kidney function?
  12. Predicting non-diabetic renal disease in type 2 diabetic adults: The value of glycated hemoglobin
  13. Joint UK societies' 2014 consensus statement on renal denervation for resistant hypertension
  14. Acute Care QUAliTy in chronic Kidney disease (ACQUATIK): a prospective cohort study exploring outcomes of patients with chronic kidney disease
  15. Cinacalcet, fibroblast growth factor-23, and cardiovascular disease in hemodialysis: The evaluation of cinacalcet HCl therapy to lower cardiovascular events (EVOLVE) trial
  16. The effects of cinacalcet in older and younger patients on hemodialysis: The evaluation of cinacalcet HCL therapy to lower cardiovascular events (EVOLVE) trial
  17. The role of the kidney and the sympathetic nervous system in hypertension
  18. Cost of treating diabetic kidney disease
  19. Does community-wide chronic kidney disease management improve patient outcomes?
  20. Percutaneous and surgical peritoneal dialysis catheter placements have comparable outcomes in the modern era
0